Heineken warns pubs over weight-loss drugs impact
Heineken has urged British pubs to adapt to the rising popularity of weight-loss drugs. The brewer warned that medications like Ozempic reduce the desire to drink and threaten beer sales.
Xurve View
Insights:
Xurve View
HEINEKEN NV warned British venues to adapt as surging weight-loss drug use threatens beer sales, according to a company presentation. The warning is a rare admission from a major brewer that GLP-1 medications impact alcohol demand.
